These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34866181)

  • 1. Tocilizumab for severe refractory primary central nervous system vasculitis: A center experience.
    Cabreira V; Dias L; Fernandes B; Aires A; Guimarães J; Abreu P; Azevedo E
    Acta Neurol Scand; 2022 Apr; 145(4):479-483. PubMed ID: 34866181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy.
    Salvarani C; Brown RD; Calamia KT; Christianson TJ; Huston J; Meschia JF; Giannini C; Miller DV; Hunder GG
    Rheumatology (Oxford); 2008 Nov; 47(11):1671-7. PubMed ID: 18753193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary CNS vasculitis: A systematic review on clinical characteristics associated with abnormal biopsy and angiography.
    Krawczyk M; Barra LJ; Sposato LA; Mandzia JL
    Autoimmun Rev; 2021 Jan; 20(1):102714. PubMed ID: 33197577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of angiography and cerebral biopsy results for suspected primary central nervous system vasculitis: A multi-center retrospective review.
    Raghavan A; Wright JM; Huang Wright C; Shammassian BH; Onyewadume L; Momotaz H; Burant CJ; Sajatovic M; Carandang R; Furlan A; Calabrese L; DeGeorgia M
    Clin Neurol Neurosurg; 2019 Oct; 185():105482. PubMed ID: 31421586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term remission, relapses and maintenance therapy in adult primary central nervous system vasculitis: A single-center 35-year experience.
    Salvarani C; Brown RD; Christianson TJH; Huston J; Giannini C; Hunder GG
    Autoimmun Rev; 2020 Apr; 19(4):102497. PubMed ID: 32062032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumefactive Primary Central Nervous System Vasculitis: Imaging Findings of a Rare and Underrecognized Neuroinflammatory Disease.
    Suthiphosuwan S; Bharatha A; Hsu CC; Lin AW; Maloney JA; Munoz DG; Palmer CA; Osborn AG
    AJNR Am J Neuroradiol; 2020 Nov; 41(11):2075-2081. PubMed ID: 32883666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system vasculitis and its mimicking diseases - clinical features, outcome, comorbidities and diagnostic results - A case control study.
    Becker J; Horn PA; Keyvani K; Metz I; Wegner C; Brück W; Heinemann FM; Schwitalla JC; Berlit P; Kraemer M
    Clin Neurol Neurosurg; 2017 May; 156():48-54. PubMed ID: 28324788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels.
    Salvarani C; Brown RD; Calamia KT; Christianson TJH; Huston J; Meschia JF; Giannini C; Miller DV; Hunder GG
    Medicine (Baltimore); 2008 Sep; 87(5):264-271. PubMed ID: 18794709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-Enhanced Magnetic Resonance Imaging, Perfusion Magnetic Resonance Imaging, and 1H-Magnetic Resonance Spectroscopy Distinguish Primary Central Nervous System Vasculitis from Glioblastoma.
    Kawazoe Y; Ohba S; Murayama K; Nakae S; Nishiyama Y; Abe M; Hasegawa M; Hirose Y
    World Neurosurg; 2022 Feb; 158():e820-e828. PubMed ID: 34813936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating endothelial cells as potential diagnostic biomarkers in primary central nervous system vasculitis.
    Deb-Chatterji M; Gerdes S; Heeren M; Lambrecht J; Worthmann H; Goldbecker A; Tryc AB; Lovric S; Schulz-Schaeffer W; Brandis A; Dengler R; Weissenborn K; Haubitz M
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):732-4. PubMed ID: 23243263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome.
    Salvarani C; Brown RD; Calamia KT; Christianson TJ; Huston J; Meschia JF; Giannini C; Miller DV; Hunder GG
    Arthritis Rheum; 2008 Feb; 58(2):595-603. PubMed ID: 18240248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis.
    Vera-Lastra O; Sepúlveda-Delgado J; Cruz-Domínguez Mdel P; Medina G; Casarrubias-Ramírez M; Molina-Carrión LE; Pineda-Galindo LF; Olvera-Acevedo A; Hernández-Gonzalez C; Jara LJ
    Clin Rheumatol; 2015 Apr; 34(4):729-38. PubMed ID: 25425493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pearls & Oy-sters: Tumour-Like Mass Lesion Secondary to Primary CNS Vasculitis.
    Roberts JI; Ng D; Kapadia R
    Neurology; 2024 Oct; 103(7):e209819. PubMed ID: 39255434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary CNS vasculitis (PCNSV): a cohort study.
    Agarwal A; Sharma J; Srivastava MVP; Sharma MC; Bhatia R; Dash D; Goyal V; Srivastava AK; Tripathi M; Suri V; Singh MB; Agarwal S; Sarkar C; Joseph L; Singh M; Suri A; Singh RK; Vibha D; Pandit AK; Rajan R; Gupta A; Elavarasi A; Radhakrishnan DM; Das A; Gaikwad S; Tandon V; Doddamani R; Upadhyay A; Garg A; Vishnu VY
    Sci Rep; 2022 Aug; 12(1):13494. PubMed ID: 35931755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of susceptibility-weighted imaging & contrast-enhanced MRI in the diagnosis of primary CNS vasculitis: a large case series.
    Agarwal S; Sebastian LJD; Gaikwad S; Srivastava MVP; Sharma MC; Singh M; Bhatia R; Agarwal A; Sharma J; Dash D; Goyal V; Srivastava AK; Tripathi M; Suri V; Singh MB; Sarkar C; Suri A; Singh RK; Vibha D; Pandit AK; Rajan R; Gupta A; Elavarasi A; Radhakrishnan DM; Das A; Tandon V; Doddamani R; Upadhyay A; Vishnu VY; Garg A
    Sci Rep; 2024 Feb; 14(1):4718. PubMed ID: 38413676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients.
    Salvarani C; Brown RD; Christianson T; Miller DV; Giannini C; Huston J; Hunder GG
    Medicine (Baltimore); 2015 May; 94(21):e738. PubMed ID: 26020379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapidly progressive primary central nervous system vasculitis.
    Salvarani C; Brown RD; Calamia KT; Christianson TJ; Huston J; Meschia JF; Giannini C; Miller DV; Hunder GG
    Rheumatology (Oxford); 2011 Feb; 50(2):349-58. PubMed ID: 20959356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics, brain magnetic resonance imaging findings and diagnostic approach of the primary central nervous system vasculitis according to angiographic classification.
    Shimoyama T; Uchino K; Calabrese LH; Hajj-Ali RA
    Clin Exp Rheumatol; 2023 Apr; 41(4):800-811. PubMed ID: 37073640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumefactive Primary Central Nervous System Vasculitis: Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging Findings With Histological Correlation.
    Muccio CF; Di Lorenzo L; Lepore G; Savarese F; Schipani S; Chiarotti I; Cerase A
    Clin Ter; 2024; 175(2):112-117. PubMed ID: 38571468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil as induction and maintenance immunosuppressive therapy in adult primary central nervous system vasculitis: A prospective observational study.
    Das S; Goswami RP; Sinha D; Shobhana A; Purkayastha S; Datta A
    Clin Rheumatol; 2023 Aug; 42(8):2155-2162. PubMed ID: 37069367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.